View in EDS

The cardiovascular safety of antiobesity drugs-analysis of signals in the FDA Adverse Event Report System Database.

Saved in:
Bibliographic Details
Title: The cardiovascular safety of antiobesity drugs-analysis of signals in the FDA Adverse Event Report System Database.
Authors: Gorelik E; Division of Clinical Pharmacy, Faculty of Medicine, School of Pharmacy, The Institute for Drug Research, The Hebrew University of Jerusalem, Jerusalem, Israel., Gorelik B, Masarwa R; Division of Clinical Pharmacy, Faculty of Medicine, School of Pharmacy, The Institute for Drug Research, The Hebrew University of Jerusalem, Jerusalem, Israel., Perlman A; Division of Clinical Pharmacy, Faculty of Medicine, School of Pharmacy, The Institute for Drug Research, The Hebrew University of Jerusalem, Jerusalem, Israel., Hirsh-Raccah B; Division of Clinical Pharmacy, Faculty of Medicine, School of Pharmacy, The Institute for Drug Research, The Hebrew University of Jerusalem, Jerusalem, Israel., Matok I; Division of Clinical Pharmacy, Faculty of Medicine, School of Pharmacy, The Institute for Drug Research, The Hebrew University of Jerusalem, Jerusalem, Israel. ilan.matok@ekmd.huji.ac.il.
Source: International journal of obesity (2005) [Int J Obes (Lond)] 2020 May; Vol. 44 (5), pp. 1021-1027. Date of Electronic Publication: 2020 Mar 09.
Publication Type: Journal Article
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101256108 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5497 (Electronic) Linking ISSN: 03070565 NLM ISO Abbreviation: Int J Obes (Lond) Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32152496
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The cardiovascular safety of antiobesity drugs-analysis of signals in the FDA Adverse Event Report System Database.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Gorelik+E%22">Gorelik E</searchLink>; Division of Clinical Pharmacy, Faculty of Medicine, School of Pharmacy, The Institute for Drug Research, The Hebrew University of Jerusalem, Jerusalem, Israel.<br /><searchLink fieldCode="AU" term="%22Gorelik+B%22">Gorelik B</searchLink><br /><searchLink fieldCode="AU" term="%22Masarwa+R%22">Masarwa R</searchLink>; Division of Clinical Pharmacy, Faculty of Medicine, School of Pharmacy, The Institute for Drug Research, The Hebrew University of Jerusalem, Jerusalem, Israel.<br /><searchLink fieldCode="AU" term="%22Perlman+A%22">Perlman A</searchLink>; Division of Clinical Pharmacy, Faculty of Medicine, School of Pharmacy, The Institute for Drug Research, The Hebrew University of Jerusalem, Jerusalem, Israel.<br /><searchLink fieldCode="AU" term="%22Hirsh-Raccah+B%22">Hirsh-Raccah B</searchLink>; Division of Clinical Pharmacy, Faculty of Medicine, School of Pharmacy, The Institute for Drug Research, The Hebrew University of Jerusalem, Jerusalem, Israel.<br /><searchLink fieldCode="AU" term="%22Matok+I%22">Matok I</searchLink>; Division of Clinical Pharmacy, Faculty of Medicine, School of Pharmacy, The Institute for Drug Research, The Hebrew University of Jerusalem, Jerusalem, Israel. ilan.matok@ekmd.huji.ac.il.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101256108%22">International journal of obesity (2005)</searchLink> [Int J Obes (Lond)] 2020 May; Vol. 44 (5), pp. 1021-1027. <i>Date of Electronic Publication: </i>2020 Mar 09.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101256108 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-5497 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203070565%22">03070565 </searchLink><i>NLM ISO Abbreviation: </i>Int J Obes (Lond) <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32152496
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41366-020-0544-4
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1021
    Titles:
      – TitleFull: The cardiovascular safety of antiobesity drugs-analysis of signals in the FDA Adverse Event Report System Database.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Gorelik E
      – PersonEntity:
          Name:
            NameFull: Gorelik B
      – PersonEntity:
          Name:
            NameFull: Masarwa R
      – PersonEntity:
          Name:
            NameFull: Perlman A
      – PersonEntity:
          Name:
            NameFull: Hirsh-Raccah B
      – PersonEntity:
          Name:
            NameFull: Matok I
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2020 May
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 1476-5497
          Numbering:
            – Type: volume
              Value: 44
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: International journal of obesity (2005)
              Type: main
ResultId 1